Annovis Bio, Inc. (ANVS) DCF Valuation

Annovis Bio, Inc. (ANVS) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Annovis Bio, Inc. (ANVS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or an analyst, this (ANVS) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from Annovis Bio, Inc., you can adjust forecasts and instantly observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 .0 .0 .0 -45.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 1.6 6.6 14.5 25.5 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -1.6 -6.6 -14.5 -25.5 -45.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 8.1 45.7 28.4 5.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .7 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories -745.6 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.2 .3 .7 4.0 1.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -.5 -5.2 -14.5 -25.3 -45.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 747.3 -744.3 .4 3.5 -47.7 -1.3 .0 .0 .0 .0
WACC, % 12.49 12.49 12.49 12.49 12.49 12.49 12.49 12.49 12.49 12.49
PV UFCF
SUM PV UFCF -1.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -6
Equity Value 5
Diluted Shares Outstanding, MM 9
Equity Value Per Share 0.51

What You Will Receive

  • Comprehensive Financial Model: Annovis Bio, Inc.'s (ANVS) real data supports accurate DCF valuation.
  • Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Real-Time Calculations: Automatic updates provide immediate feedback as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, allowing for repeated application in detailed financial forecasts.

Key Features

  • 🔍 Real-Life ANVS Financials: Pre-filled historical and projected data for Annovis Bio, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Annovis Bio’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Annovis Bio’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template with Annovis Bio, Inc.'s (ANVS) data included.
  • Step 2: Explore the pre-filled sheets and understand the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Annovis Bio, Inc.'s (ANVS) intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose Annovis Bio, Inc. (ANVS)?

  • Innovative Solutions: Pioneering research and development in neurodegenerative diseases.
  • Robust Science: Backed by solid scientific evidence and clinical studies.
  • Patient-Centric Approach: Committed to improving the lives of patients through targeted therapies.
  • Experienced Leadership: Led by a team of industry veterans with a proven track record.
  • Growth Potential: Positioned for significant advancements in the biopharmaceutical sector.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Annovis Bio, Inc. (ANVS) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Annovis Bio, Inc. (ANVS).
  • Consultants: Deliver professional valuation insights on Annovis Bio, Inc. (ANVS) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Annovis Bio, Inc. (ANVS) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Annovis Bio, Inc. (ANVS).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Annovis Bio historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Annovis Bio, Inc. (ANVS).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.